Page 7 - RxExam's Naplex Theory Book Part 2
P. 7

www.pharmacyexam.com                                                                   Krisman


                                            38. BENIGN PROSTATIC HYPERPLASIA


               A). 5-Alpha-Reductase Inhibitors

               Finasteride                   =  Proscar
               Dutasteride                   =  Avodart

               B). Specific Alpha-1 Blockers: (Please Refer Chapter 10 on page 64 of Part 1)

               Prazosin                      =  Minipress
               Terazosin                     =  Hytrin
               Doxazosin                     =  Cardura, Cardura Xl
               Alfuzosin                     =  Uroxatral
               Silodosin                     =  Rapaflo

               C). Specific Alpha-1 Blockers in a Prostate Gland: (Please Refer Chapter 10 on page 64 of Part 1)

               Tamsulosin                    =  Flomax

               D). Combination Agents:

               Tamsulosin + Dutasteride      =  Jalyn


                Definition: Benign Prostatic Hyperplasia is defined as an enlargement of the prostate gland which is often
                associated with urination and bladder problems.

                A). 5-Alpha-Reductase Inhibitors

                                Dose               Special Notes

                Finasteride     1. B.P.H.          1). Finasteride (Proscar) is a specific inhibitor of steroid Type II 5α-
                (Tablet)        5 mg once a day    reductase; an intracellular enzyme that converts the androgen
                                with or without    testosterone into 5α-dihydrotestosterone (DHT). The development
                                food.              and enlargement of the prostate gland is dependent on this potent
                                                   androgen, 5α-dihydrotestosterone (DHT).
                                2. Androgenetic
                                alopecia           2). It is indicated for the treatment of symptomatic benign prostatic
                                1 mg orally once   hyperplasia (BPH) in men with an enlarged prostate to:
                                daily with or      i). Improve symptoms
                                without food.      ii). Reduce the risk of acute urinary retention (AUR)
                                                   iii). Reduce the risk of the need for surgery including transurethral
                                                   resection of the prostate (TURP) and prostatectomy.

                                                   3). In combination with the alpha-blocker Doxazosin, It is indicated to
                                                   reduce the risk of symptomatic progression of BPH.


                                                              6
   2   3   4   5   6   7   8   9   10   11   12